Help
RSS
API
Feed
Maltego
Contact
Domain > ir.q32bio.com
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2025-06-11
23.210.244.165
(
ClassC
)
2026-02-06
23.216.147.199
(
ClassC
)
Port 443
HTTP/1.1 200 OKContent-Language: enContent-Security-Policy: default-src self bam-cell.nr-data.net bam.nr-data.net cm.everesttech.net thomsonreuterscorporategroupweb.sc.omtrdc.net *.demdex.net www.google-analytics.com www.googletagmanager.com www.adobetag.com *.facebook.net api.nasdaqomx.wallst.com www.google.com *.addthis.com *.addthisedge.com www.googleadservices.com thomsonreuterscorporategroupweb.d2.sc.omtrdc.net stats.g.doubleclick.net *.sharethis.com *.pixel.parsely.com www.recaptcha.net www.gstatic.com c212.net pixel.mathtag.com cdn.kscope.io *.globenewswire.com *.accesswire.com *.businesswire.com *.prnewswire.com *.c212.net *.youtube.com *.vimeo.com *.media-server.com ds-aksb-a.akamaihd.net sec.kscope.io media.corporate-ir.net *.unisonir.com http://cloudinary.com *.segment.com uninav.notified.com *.pendo.io *.pendo.notified.com *.kscope.io data:; connect-src self *.uni.wdc.west.com *.sharethis.com *.unisonir.com *.demdex.net bam-cell.nr-data.net bam.nr-data.net api.segment.io thomsonreuterscorporategroupweb.sc.omtrdc.net *.akamaihd.net uninav.notified.com *.pendo.io *.kscope.io; font-src self fonts.googleapis.com cloud.typography.com fonts.gstatic.com uninav.notified.com stackpath.bootstrapcdn.com use.typekit.net data: *.kscope.io *.fontawesome.com; frame-src self s7.addthis.com tools.eurolandir.com www.google.com *.sharethis.com api.nasdaqomx.wallst.com *.demdex.net www.recaptcha.net cloudinary.com https://player.cloudinary.com http://login.notified.com; object-src self; script-src self unsafe-inline unsafe-eval *.recaptcha.net js-agent.newrelic.com *.jquery.com *.gstatic.com bam-cell.nr-data.net bam.nr-data.net *.akamaihd.net uninav.notified.com https://assets.adobedtm.com https://cdn.jsdelivr.net https://cdnjs.cloudflare.com https://code.jquery.com https://media-library.cloudinary.com https://uninav.notified.com https://unpkg.com https://upload-widget.cloudinary.com https://www.google.com https://www.recaptcha.net www.google.com; script-src-elem self unsafe-inline *.uni.wdc.west.com s7.addthis.com www.google.com www.googletagmanager.com www.google-analytics.com siteimproveanalytics.com cdn.parsely.com www.adobetag.com www.recaptcha.net www.gstatic.com *.sharethis.com ds-aksb-a.akamaihd.net sec.kscope.io *.unisonir.com js-agent.newrelic.com bam-cell.nr-data.net bam.nr-data.net code.jquery.com cdn.segment.com *.pendo.io *.notified.com *.kscope.io https://assets.adobedtm.com https://cdn.jsdelivr.net https://cdnjs.cloudflare.com https://code.jquery.com https://media-library.cloudinary.com https://uninav.notified.com https://unpkg.com https://upload-widget.cloudinary.com https://www.google.com https://www.recaptcha.net; style-src self unsafe-inline uninav.notified.com fonts.googleapis.com https://uninav.notified.com maxcdn.bootstrapcdn.com stackpath.bootstrapcdn.com *.typekit.net https://fonts.googleapis.com https://unpkg.com https://use.fontawesome.com; style-src-elem self unsafe-inline fonts.googleapis.com *.uni.wdc.west.com *.sharethis.com www.google.com ajax.googleapis.com sec.kscope.io *.unisonir.com www.gstatic.com stackpath.bootstrapcdn.com maxcdn.bootstrapcdn.com https://uninav.notified.com *.pendo.io *.typekit.net *.kscope.io https://fonts.googleapis.com https://unpkg.com https://use.fontawesome.com; form-action selfContent-Type: text/html; charsetUTF-8ETag: 1770376132Expect-CT: max-age0, report-uri/report-expect-ct-violationFeature-Policy: accelerometer none;ambient-light-sensor none;autoplay self;camera none;encrypted-media none;fullscreen self;geolocation self;gyroscope none;magnetometer none;microphone none;midi none;payment none;picture-in-picture none;speaker self;sync-xhr self;usb none;vibrate none;vr noneFrom-Origin: sameLast-Modified: Fri, 06 Feb 2026 11:08:52 GMTReferrer-Policy: no-referrer-when-downgradeStrict-Transport-Security: max-age31536000X-Age: 693X-Cache-Hits: 1X-Content-Type-Options: nosniffX-Drupal-Dynamic-Cache: UNCACHEABLE (poor cacheability)X-Frame-Options: SAMEORIGINX-Request-ID: v-386944aa-034c-11f1-b3ef-3318de84fa57X-XSS-Protection: 1; modeblockCache-Control: public, max-age0, s-maxage2700Expires: Fri, 06 Feb 2026 11:20:26 GMTDate: Fri, 06 Feb 2026 11:20:26 GMTContent-Length: 46328Connection: keep-alive !DOCTYPE html>html langen dirltr prefixog: https://ogp.me/ns#> head> meta charsetutf-8 />meta namedescription contentThe Investor Relations website contains information about Q32 Bio Inc.'s business for stockholders, potential investors, and financial analysts. />link relcanonical hrefhttps://ir.q32bio.com/investor-relations/ />link relshortlink hrefhttps://ir.q32bio.com/ />meta namereferrer contentno-referrer />meta propertyog:site_name contentQ32 Bio Inc. />meta propertyog:type contentwebsite />meta propertyog:url contenthttps://ir.q32bio.com/investor-relations />meta propertyog:title contentInvestors & Media - Q32 Bio Inc. />meta propertyog:description contentThe Investor Relations website contains information about Q32 Bio Inc.'s business for stockholders, potential investors, and financial analysts. />meta nameGenerator contentDrupal 10 (https://www.drupal.org) />meta nameMobileOptimized contentwidth />meta nameHandheldFriendly contenttrue />meta nameviewport contentwidthdevice-width, initial-scale1.0 />link relicon href/sites/g/files/knoqqb90916/files/favicon-Q32Bio_0.png typeimage/png />link relalternate hreflangen hrefhttps://ir.q32bio.com/ /> title>Investors & Media - Q32 Bio Inc./title> link relstylesheet mediaall href/sites/g/files/knoqqb90916/files/css/css_LyOmN9eJP9nk_w-dNeYfPbZiz28f3h52TfZ6tTUyY0U.css?delta0&languageen&themeclient_site&includeeJyNj80OgzAMg18I0UeKTIhYRpuiNPvh7VfYZTtM2u2TZSc2ZxULahqS6l384Z3awNUlzX7bkEdc8fwSZkWuy2DqNKFJOkC5WjulAl8laEaAplx5TTDkvQU5Qm3pGSe-wOMve6PAlOWHtwiMXLiWItZ1rfZxe8PybnfA2BvGuXU37iXMxIfWH0lJx4wXu3lpRA />link relstylesheet mediaall href/sites/g/files/knoqqb90916/files/css/css_lJsHKPNEYMSq_ifZIHv0h5NskAU3YLO00kaB7ny1_K8.css?delta1&languageen&themeclient_site&includeeJyNj80OgzAMg18I0UeKTIhYRpuiNPvh7VfYZTtM2u2TZSc2ZxULahqS6l384Z3awNUlzX7bkEdc8fwSZkWuy2DqNKFJOkC5WjulAl8laEaAplx5TTDkvQU5Qm3pGSe-wOMve6PAlOWHtwiMXLiWItZ1rfZxe8PybnfA2BvGuXU37iXMxIfWH0lJx4wXu3lpRA />link relstylesheet mediaall hrefhttps://use.fontawesome.com/releases/v6.4.2/css/all.css />link relstylesheet mediaall hrefhttps://fonts.googleapis.com/icon?familyMaterial+Icons />link relstylesheet mediaall hrefhttps://fonts.googleapis.com/css2?familyMaterial+Symbols+Outlined:opsz,wght,FILL,GRAD@20..48,100..700,0..1,-50..200 />link relstylesheet mediaall hrefhttps://unpkg.com/aos@2.3.1/dist/aos.css />link relstylesheet mediaall hrefhttps://unpkg.com/swiper@8/swiper-bundle.min.css />link relstylesheet mediaall href/sites/g/files/knoqqb90916/files/css/css_AgBGYy5kCdzSyKNXa6My23B_CQlJqdkImN2BaQPJzPc.css?delta7&languageen&themeclient_site&includeeJyNj80OgzAMg18I0UeKTIhYRpuiNPvh7VfYZTtM2u2TZSc2ZxULahqS6l384Z3awNUlzX7bkEdc8fwSZkWuy2DqNKFJOkC5WjulAl8laEaAplx5TTDkvQU5Qm3pGSe-wOMve6PAlOWHtwiMXLiWItZ1rfZxe8PybnfA2BvGuXU37iXMxIfWH0lJx4wXu3lpRA />link relstylesheet mediaprint href/sites/g/files/knoqqb90916/files/css/css_zft3Bl-FUnRC8hnCrT3IR36PUosgUijOkptDunHE_j0.css?delta8&languageen&themeclient_site&includeeJyNj80OgzAMg18I0UeKTIhYRpuiNPvh7VfYZTtM2u2TZSc2ZxULahqS6l384Z3awNUlzX7bkEdc8fwSZkWuy2DqNKFJOkC5WjulAl8laEaAplx5TTDkvQU5Qm3pGSe-wOMve6PAlOWHtwiMXLiWItZ1rfZxe8PybnfA2BvGuXU37iXMxIfWH0lJx4wXu3lpRA />link relstylesheet mediaall href/sites/g/files/knoqqb90916/files/css/css_B70Zx4i9INVsL1Xi4zMgS9PXJxklondb2GMPh1aDYX0.css?delta9&languageen&themeclient_site&includeeJyNj80OgzAMg18I0UeKTIhYRpuiNPvh7VfYZTtM2u2TZSc2ZxULahqS6l384Z3awNUlzX7bkEdc8fwSZkWuy2DqNKFJOkC5WjulAl8laEaAplx5TTDkvQU5Qm3pGSe-wOMve6PAlOWHtwiMXLiWItZ1rfZxe8PybnfA2BvGuXU37iXMxIfWH0lJx4wXu3lpRA /> script src/core/assets/vendor/modernizr/modernizr.min.js?v3.11.7>/script>script src/sites/g/files/knoqqb90916/files/js/js_NOB0yXhUl2Rh03NlIEXredl3UnIe78OIXQNxEOFtNZ4.js?scopeheader&delta1&languageen&themeclient_site&includeeJyVUFsOAjEIvJBpz-IJCKVE69KyaVkft7d2NWaNHxoSmBmGBCBJXAxaMvZ65nqpHbVdSRWwoNwsUfMb5jBqYBBcCh1_MM5V47DRxDGZVohoPYJw8284LBnrxDYMEERp8l9VR5ozlvjXTLOe94sar2OLWMp9I_RbOrozHti_gMMTXgFjBBJsDVC42rrwhcPjdVC0X8zrAz4096x3KCyQDg>/script> /head> body classnir-node nir-node--type-nir-landing-page nir-node--5806 reborn_lite path-frontpage page-node-type-nir-landing-page> div idskip> a classvisually-hidden focusable skip-link href#main-menu> Skip to main navigation /a> /div> div classdialog-off-canvas-main-canvas data-off-canvas-main-canvas> header classd-flex flex-column> nav classndm-main-nav ndm-interstitial navbar navbar-light navbar-expand-xl fixed-top py-0 ndm-navBg aria-labelMain Navigation> div classcontainer-xl px-0 px-3> a classnavbar-brand py-4 me-xl-4 d-flex align-items-center hrefhttps://www.q32bio.com/ aria-labelLink to Q32 Bio Inc. homepage> div classme-2> img src/sites/g/files/knoqqb90916/themes/site/client_site/dist/images/site-logo.png altQ32 Bio Inc. Logo> /div> /a> button classnavbar-toggler typebutton data-bs-togglecollapse data-bs-target#navbarNav aria-controlsnavbarNav aria-expandedfalse aria-labelToggle navigation> span classnavbar-toggler-icon>span>/span>/span> /button> div classcollapse navbar-collapse idnavbarNav> ul classnavbar-nav flex-grow-1 justify-content-xl-end> li classnav-item active-trail> a href/investor-relations class nav-link is-active data-bs-toggle aria-expandedfalse data-drupal-link-system-pathnode/5806 aria-currentpage>Overview/a> /li> li classdropdown nav-item> a href/news-and-events/news-releases class dropdown-toggle nav-link data-bs-toggledropdown aria-expandedfalse data-drupal-link-system-pathnode/5816>News & Events/a> ul classdropdown-menu> li> a href/news-and-events/news-releases class dropdown-item data-bs-toggle aria-expandedfalse data-drupal-link-system-pathnode/5816>News Releases/a> /li> li> a href/news-and-events/events-presentations class dropdown-item data-bs-toggle aria-expandedfalse data-drupal-link-system-pathnode/5821>Events & Presentations/a> /li> /ul> /li> li classdropdown nav-item> a href/financial-and-filings/sec-filings class dropdown-toggle nav-link data-bs-toggledropdown aria-expandedfalse data-drupal-link-system-pathnode/6016>Financials & Filings/a> ul classdropdown-menu> li> a href/financial-and-filings/sec-filings class dropdown-item data-bs-toggle aria-expandedfalse data-drupal-link-system-pathnode/6016>SEC Filings/a> /li> /ul> /li> li classdropdown nav-item> a href/stock-information/stock-quote-and-chart class dropdown-toggle nav-link data-bs-toggledropdown aria-expandedfalse data-drupal-link-system-pathnode/5916>Stock Information/a> ul classdropdown-menu> li> a href/stock-information/stock-quote-and-chart class dropdown-item data-bs-toggle aria-expandedfalse data-drupal-link-system-pathnode/5916>Stock Quote & Chart/a> /li> /ul> /li> li classnav-item> a href/analyst-coverage class nav-link data-bs-toggle aria-expandedfalse data-drupal-link-system-pathnode/5896>Analyst Coverage/a> /li> li classdropdown nav-item> a href/corporate-governance/documents-charters class dropdown-toggle nav-link data-bs-toggledropdown aria-expandedfalse data-drupal-link-system-pathnode/5836>Corporate Governance/a> ul classdropdown-menu> li> a href/corporate-governance/documents-charters class dropdown-item data-bs-toggle aria-expandedfalse data-drupal-link-system-pathnode/5836>Documents & Charters/a> /li> li> a hrefhttps://www.q32bio.com/our-team/ target_blank class dropdown-item data-bs-toggle aria-expandedfalse>Management Team/a> /li> li> a hrefhttps://www.q32bio.com/our-team/ target_blank class dropdown-item data-bs-toggle aria-expandedfalse>Board of Directors/a> /li> li> a href/corporate-governance/committee-composition class dropdown-item data-bs-toggle aria-expandedfalse data-drupal-link-system-pathnode/5851>Committee Composition/a> /li> /ul> /li> li classdropdown nav-item> a href/investor-resources/investor-email-alerts class dropdown-toggle nav-link data-bs-toggledropdown aria-expandedfalse data-drupal-link-system-pathnode/5946>Investor Resources/a> ul classdropdown-menu> li> a href/investor-resources/investor-faqs class dropdown-item data-bs-toggle aria-expandedfalse data-drupal-link-system-pathnode/5941>Investor FAQs/a> /li> li> a href/investor-resources/investor-email-alerts class dropdown-item data-bs-toggle aria-expandedfalse data-drupal-link-system-pathnode/5946>Investor Email Alerts/a> /li> li> a href/investor-resources/contact-ir class dropdown-item data-bs-toggle aria-expandedfalse data-drupal-link-system-pathnode/5981>Contact IR/a> /li> /ul> /li> /ul> /div> /div>/nav> /header> main classclearfix ndm-pt-7 idmain rolemain> div classjumbotron mb-5 rounded-3 container ndm-full-image-sect ndm-overlay-opac-3 ndm-overlay-primary flex-grow-1 ndm-overlay d-flex flex-column bg-dark bg-gradient-rev> div classcontainer px-5 position-relative d-flex flex-column flex-grow-1 justify-content-center ndm-pt-7 ndm-pb-7> div classrow> div classcol-12 col-xl-10 col-xxl-12> div classrow text-center> div classcol-12> h1 classmb-0>Investors & Media/h1> /div> /div> /div> /div> /div> /div> div idcontent> div idcontent-area> div classlf-5806 idlfg-content> div classregion region-content> div idblock-client-site-websitenoticeblock classblock--website-notice-block block--website-notice-block--5806 block--content--website-notice-block block--content--website-notice-block--5806 block--50753ea7-062d-4c23-8631-c7dd071aa989 block--50753ea7-062d-4c23-8631-c7dd071aa989--5806 block block-nir-website-notices block-website-notice-block> /div>div data-drupal-messages-fallback classhidden>/div>div idblock-client-site-content classblock--system-main-block block--system-main-block--5806 block--content--system-main-block block--content--system-main-block--5806 block--19970799-2da7-41d0-9bd2-74fac269dec0 block--19970799-2da7-41d0-9bd2-74fac269dec0--5806 block block-system block-system-main-block> article classnode node--type-nir_landing_page node--view-mode-full clearfix> div> div classpanel-display pond clearfix> section classpy-3> div classcontainer px-5> div classrow gx-5 gy-4 gy-md-0 justify-content-between> div classcol-md-12> div classradix-layouts-header panel-panel> div classpanel-panel-inner> div classblock-region-header>div classblock-content--nir-global-block block-content--nir-global-block--6116 block--block-contentf390be37-9ad7-4a7e-a354-7aad647bf74c block--block-contentf390be37-9ad7-4a7e-a354-7aad647bf74c--5806 block--header--block-content--f390be37-9ad7-4a7e-a354-7aad647bf74c block--header--block-content--f390be37-9ad7-4a7e-a354-7aad647bf74c--5806 block--62a3f554-e81b-4368-97e5-6d45e942029b block--62a3f554-e81b-4368-97e5-6d45e942029b--5806 block block-block-content block-block-contentf390be37-9ad7-4a7e-a354-7aad647bf74c> h2>Corporate Profile/h2> div classfield field--name-field-nir-global-block-node field--type-entity-reference field--label-hidden field__item> div classfield field--name-field-nir-global-block-body field--type-text-long field--label-hidden field__item>p>Q32 Bio is a clinical stage biotechnology company whose science targets potent regulators of the adaptive immune system to re-balance immunity and is focused on developing innovative therapies for alopecia areata and other autoimmune and inflammatory diseases. Per the National Alopecia Areata Foundation, about 700,000 people in the United States live with alopecia areata, a disease which has a life-altering impact on patients and limited current treatment options. The Company is advancing bempikibart (ADX-914), a fully human anti-IL-7Rα antibody that re-regulates adaptive immune function, for the treatment of alopecia areata in an ongoing Phase 2 program. The IL-7 and TSLP pathways have been genetically and biologically implicated in driving several T cell-mediated pathological processes in numerous autoimmune diseases./p>/div> /div> /div>/div> /div> /div> /div> /div> /div> /section> section classpy-3> div classcontainer py-5 px-5> div classradix-layouts-column2 panel-panel> div classpanel-panel-inner> div classblock-region-column2>div classblock--tw-news-millennium block--nir-news__widget block--nir-news__widget--5806 block--column2--nir-news__widget block--column2--nir-news__widget--5806 block--b3af3232-d742-4a34-8f78-0b8cc1cda1c2 block--b3af3232-d742-4a34-8f78-0b8cc1cda1c2--5806 block block-nir-news block-nir-news__widget> div classnir-widget llf-container-fluid-full> div classllf-row llf-no-gutters> div classllf-col-12> div classd-flex flex-row justify-content-between align-items-end> h2 classnir-widget--label lh-1 mb-0>News Releases/h2> div classtext-md-end weight-bold lh-1 ps-3> a hrefhttps://ir.q32bio.com/news-and-events/news-releases classndm-learn-more ndm-hover-fill lh-1>span>All News Releases/span>/a> /div> /div> div classnir-widget--content> div classnir-widget--list > div classrow row-cols-1 row-cols-sm-1 row-cols-xl-3 gx-5 gy-5 pt-4> article classclearfix node node--nir-news--nir-widget-list node--type-nir-news node--view-mode-nir-widget-list node--promoted col data-titleQ32 Bio Sells Complement Inhibitor ADX-097> div classllf-col-md-12 llf-px-0 lfg-details > div classnir-widget--field nir-widget--news--date-time data-labelDate> December 1, 2025 /div> div classnir-widget--field data-labelTitle> a class weight-600 d-block href/news-releases/news-release-details/q32-bio-sells-complement-inhibitor-adx-097>Q32 Bio Sells Complement Inhibitor ADX-097/a> /div> /div> /article> article classclearfix node node--nir-news--nir-widget-list node--type-nir-news node--view-mode-nir-widget-list node--promoted col data-titleQ32 Bio Reports Third Quarter 2025 Financial Results and Provides Corporate Update> div classllf-col-md-12 llf-px-0 lfg-details > div classnir-widget--field nir-widget--news--date-time data-labelDate> November 13, 2025 /div> div classnir-widget--field data-labelTitle> a class weight-600 d-block href/news-releases/news-release-details/q32-bio-reports-third-quarter-2025-financial-results-and>Q32 Bio Reports Third Quarter 2025 Financial Results and Provides Corporate Update/a> /div> /div> /article> article classclearfix node node--nir-news--nir-widget-list node--type-nir-news node--view-mode-nir-widget-list node--promoted col data-titleQ32 Bio Announces Completion of Enrollment in Part B of SIGNAL-AA Phase 2a Clinical Trial of Bempikibart for Alopecia Areata> div classllf-col-md-12 llf-px-0 lfg-details > div classnir-widget--field nir-widget--news--date-time data-labelDate> October 21, 2025 /div> div classnir-widget--field data-labelTitle> a class weight-600 d-block href/news-releases/news-release-details/q32-bio-announces-completion-enrollment-part-b-signal-aa-phase>Q32 Bio Announces Completion of Enrollment in Part B of SIGNAL-AA Phase 2a Clinical Trial of Bempikibart for Alopecia Areata/a> /div> /div> /article> /div> /div> /div> /div> /div> /div> /div>/div> /div> /div> /div> /section> section classpy-3> div classcontainer px-5> div classradix-layouts-column3 panel-panel h-100> div classpanel-panel-inner h-100> div classblock-region-column3>div data-storage-idnode:5806:full:24421 data-uuid4cf2ae31-1cf3-4a10-8b90-247166a74194 classblock--market-data-block__stock-quote block--market-data-block__stock-quote--5806 block--column3--market-data-block__stock-quote block--column3--market-data-block__stock-quote--5806 block--4cf2ae31-1cf3-4a10-8b90-247166a74194 block--4cf2ae31-1cf3-4a10-8b90-247166a74194--5806 block block-nir-market-data-block block-market-data-block__stock-quote> h2>Stock Quote/h2> div classquote-wrap user-toggle-off long-quote > div classquote-wrapper> div classstock-quote lfg-stock-quote llf-container-fluid data-exchange> div classllf-row llf-align-items-center llf-align-items-stretch> div classllf-col-lg-3 llf-col-12 lfg-price-container> div classexchange>/div> div classquote-price >/div> time>/time> /div> div classllf-col-lg-9 llf-col-md-12 llf-col-sm-12 llf-d-flex> div classllf-row llf-flex-grow-1> div classlfg-stock-data-column llf-col-md-6 llf-d-flex llf-flex-column llf-justify-content-between> div classllf-row stock-price-change> div classllf-col-6 lfg-stock-label>Change/div> div classllf-col-6 lfg-stock-data >/div> /div> div classllf-row stock-volume> div classllf-col-6 lfg-stock-label>Volume/div> div classllf-col-6 lfg-stock-data>/div> /div> div classllf-row stock-day-open> div classllf-col-6 lfg-stock-label>Todays Open/div> div classllf-col-6 lfg-stock-data>/div> /div> div classllf-row stock-prev-close> div classllf-col-6 lfg-stock-label>Previous Close/div> div classllf-col-6 lfg-stock-data>/div> /div> /div> div classlfg-stock-data-column llf-col-md-6 llf-d-flex llf-flex-column llf-justify-content-between> div classllf-row stock-day-high> div classllf-col-6 lfg-stock-label>Todays High/div> div classllf-col-6 lfg-stock-data>/div> /div> div classllf-row stock-day-low> div classllf-col-6 lfg-stock-label>Todays Low/div> div classllf-col-6 lfg-stock-data>/div> /div> div classllf-row stock-year-high> div classllf-col-6 lfg-stock-label>52 Week High/div> div classllf-col-6 lfg-stock-data>/div> /div> div classllf-row stock-year-low> div classllf-col-6 lfg-stock-label>52 Week Low/div> div classllf-col-6 lfg-stock-data>/div> /div> /div> /div> /div> /div> /div> /div>/div> /div>div classblock--attribution-block__stock-info-attribution__thomson-reuters block--attribution-block__stock-info-attribution__thomson-reuters--5806 block--column3--attribution-block__stock-info-attribution__thomson-reuters block--column3--attribution-block__stock-info-attribution__thomson-reuters--5806 block--12527a7e-dbd1-466a-8144-75f9aa0f485a block--12527a7e-dbd1-466a-8144-75f9aa0f485a--5806 block block-nir-attribution-block block-attribution-block__stock-info-attribution__thomson-reuters> p classattribution-legend> Minimum 15 minutes delayed. Source: LSEG/p> /div>/div> /div> /div> /div> /section> section classpy-3> div classcontainer py-5 px-5> div classrow gx-5> div classcol-md-6 mb-5 mb-md-0> div classradix-layouts-secondarycolumn2 panel-panel> div classpanel-panel-inner mb-5 mb-md-0> div classblock-region-secondarycolumn2>div classblock--tw-cvr block--nir-assets__widget block--nir-assets__widget--5806 block--secondarycolumn2--nir-assets__widget block--secondarycolumn2--nir-assets__widget--5806 block--91de9f44-91f4-4753-9636-95edec328ec8 block--91de9f44-91f4-4753-9636-95edec328ec8--5806 block block-nir-assets block-nir-assets__widget> div classnir-widget llf-container-fluid-full> div classllf-row llf-no-gutters> div classllf-col-12> h2 classnir-widget--label lh-1>Latest Presentation/h2> div classnir-widget--content> div classnir-widget--list > div classrow row-cols-1 row-cols-sm-2 gy-4 pt-4 mb-4> article classclearfix node node--nir-asset--nir-widget-list node--type-nir-asset node--view-mode-nir-widget-list col data-titleCorporate Presentation> a href/static-files/331d19d0-d8a0-45ab-b633-be53859468e5 target_blank classportrait d-block bg-dark rounded-3 ndm-overlay-primary ndm-overlay-opac-5> img classhover-scale-1 src/sites/g/files/knoqqb90916/themes/site/client_site/dist/images/reports_homepage_fallback/reports_auto_6.jpg alt> div classd-flex flex-column align-items-center justify-content-end p-4> div classh5 text-center>Corporate Presentation/div> /div> /a> /article> /div> /div> /div> /div> /div> /div> /div> nav rolenavigation aria-labelSee All Presentations classblock--system-menu-blocksee-all-reports block--system-menu-blocksee-all-reports--5806 block--secondarycolumn2--system-menu-block--see-all-reports block--secondarycolumn2--system-menu-block--see-all-reports--5806 block--b6fdde97-c2f8-4ecc-a4c5-c3dfd96717f4 block--b6fdde97-c2f8-4ecc-a4c5-c3dfd96717f4--5806 block block-menu navigation block-system-menublock menu--see-all-reports> ul data-block-uuidb6fdde97-c2f8-4ecc-a4c5-c3dfd96717f4 classmenu side-menu> li classside-menu__item> a href/news-and-events/events-presentations classbtn btn-lg btn-primary data-drupal-link-system-pathnode/5821>See All Presentations/a> /li> /ul> /nav> /div> /div> /div> /div> div classcol-md-6> div classradix-layouts-secondarycolumn3 panel-panel> div classpanel-panel-inner> div classblock-region-secondarycolumn3>div classblock--tw-events-millennium block--nir-events__widget block--nir-events__widget--5806 block--secondarycolumn3--nir-events__widget block--secondarycolumn3--nir-events__widget--5806 block--be98b72d-b0bb-4afe-bc65-abd0aba8e1ba block--be98b72d-b0bb-4afe-bc65-abd0aba8e1ba--5806 block block-nir-events block-nir-events__widget> div classnir-widget llf-container-fluid-full> div classllf-row llf-no-gutters> div classllf-col-12> div classd-flex flex-row justify-content-between align-items-end mb-4> div> h2 classnir-widget--label lh-1 mb-0>Events/h2> /div> div classtext-md-end weight-bold lh-1 ps-3> a hrefhttps://ir.q32bio.com/news-and-events/events-presentations classndm-learn-more ndm-hover-fill lh-1>span>All Events/span>/a> /div> /div> div classnir-widget--content> div classnir-widget--list > article classlfg-no-content nir-widget-article>Investor Events will be posted soon./article> /div> /div> /div> /div> /div> /div>div classblock--tw-events-millennium block--nir-events__widget block--nir-events__widget--5806 block--secondarycolumn3--nir-events__widget block--secondarycolumn3--nir-events__widget--5806 block--06cd93ff-bfc8-4a54-9972-734d108144c5 block--06cd93ff-bfc8-4a54-9972-734d108144c5--5806 block block-nir-events block-nir-events__widget> div classnir-widget llf-container-fluid-full> div classllf-row llf-no-gutters> div classllf-col-12> div classnir-widget--content> div classnir-widget--list > article classclearfix node node--nir-event--nir-widget-list node--type-nir-event node--view-mode-nir-widget-list d-flex align-items-center border-bottom py-4 row gx-0 data-title2025 Wells Fargo Healthcare Conference> h3 classh6 mb-0>span classndm-eyebrow font-14>Past Event/span>/h3> div classcol-12> div classd-flex justify-content-between w-100> div classflex-grow-1 pe-4> div classnir-widget--field nir-widget--event--title weight-600> a href/events/event-details/2025-wells-fargo-healthcare-conference class>2025 Wells Fargo Healthcare Conference/a> /div> div classnir-widget--field nir-widget--event--date mt-0> September 4, 2025 span classlfg_time>3:45 PM EDT/span> /div> /div> div> a href/events/event-details/2025-wells-fargo-healthcare-conference classbtn-galaxy-black-arrow-right justify-content-between no-border aria-label2025 Wells Fargo Healthcare Conference>span>/span> /a> /div> /div> /div>/article> /div> /div> /div> /div> /div> /div>/div> /div> /div> /div> /div> /div> /section> /div>!-- /.radix-pond --> /div>/article> /div> /div> /div> /div> /div> /main>footer classbg-primary text-white> div classcontainer p-5 position-relative sign-up-for-email-alerts> div classrow gx-5 justify-content-between> div classcol-md-6 mb-5 mb-md-0> div classregion region-template-footer> div idblock-client-site-globalinvestorcontact classblock-content--nir-global-block block-content--nir-global-block--9431 block--block-contentfa0e8713-7c9a-4596-b69b-77300e237573 block--block-contentfa0e8713-7c9a-4596-b69b-77300e237573--5806 block--template-footer--block-content--fa0e8713-7c9a-4596-b69b-77300e237573 block--template-footer--block-content--fa0e8713-7c9a-4596-b69b-77300e237573--5806 block--7571d86b-8fc3-4aed-9ec1-976d1b45e34b block--7571d86b-8fc3-4aed-9ec1-976d1b45e34b--5806 block block-block-content block-block-contentfa0e8713-7c9a-4596-b69b-77300e237573> div classfield field--name-field-nir-global-block-node field--type-entity-reference field--label-hidden field__item> div classfield field--name-field-nir-global-block-body field--type-text-long field--label-hidden field__item>h2 classh5 text-white>Investor Contact/h2>p>Argot Partners/p>div classd-flex align-items-center my-2>span aria-hiddentrue classmaterial-symbols-outlined me-2>drafts/span> a hrefmailto:Q32Bio@argotpartners.com>Q32Bio@argotpartners.com/a>/div>div classd-flex align-items-center my-2>span aria-hiddentrue classmaterial-symbols-outlined me-2>phone_iphone/span> +212 600-1902/div>/div> /div> /div> /div> /div> div classcol-md-6> form actionhttps://ir.q32bio.com/investor-resources/investor-email-alerts> div idblock-client-site-globalemailalerts classblock-content--nir-global-block block-content--nir-global-block--9436 block--block-content8ce3fc5f-b577-4d13-a559-8677a6627dbd block--block-content8ce3fc5f-b577-4d13-a559-8677a6627dbd--5806 block--email-alerts--block-content--8ce3fc5f-b577-4d13-a559-8677a6627dbd block--email-alerts--block-content--8ce3fc5f-b577-4d13-a559-8677a6627dbd--5806 block--3516403e-2b52-45e6-afc6-9fe4ec19fc53 block--3516403e-2b52-45e6-afc6-9fe4ec19fc53--5806 block block-block-content block-block-content8ce3fc5f-b577-4d13-a559-8677a6627dbd> div classfield field--name-field-nir-global-block-node field--type-entity-reference field--label-hidden field__item> div classfield field--name-field-nir-global-block-body field--type-text-long field--label-hidden field__item>label classh5 mb-3 d-block forexampleInputEmail1>Subscribe to our Email Alerts/label>div classrow g-3>div classcol>input classform-control h-100 idexampleInputEmail1 namenir_email_alerts_signup_email placeholderEmail Address typeemail>/div>div classcol-auto>button classbtn btn-primary typesubmit>Submit/button>/div>/div>/div> /div> /div> /form> /div> /div> /div> div classbg-dark bg-primary> div classcontainer px-5> div classrow align-items-center gx-5> div classcol-10 col-md-8> div classsmall>© 2026 Q32 Bio Inc./div> /div> div classcol-2 col-md-4> div classregion region-social-links> nav aria-labelsocial media links classjustify-content-end navbar navbar-dark navbar-expand> h2 classvisually-hidden text-center idblock-client-site-sitesocialmedia-menu>Site - Social Media/h2> ul classnavbar-nav navbar-expand> li classnav-item> a hrefhttps://twitter.com/Q32Bio aria-labelTwitter opens in new window titleTwitter opens in new window classnav-link hover-scale-1 d-block target_blank> i classfab fa-lg fa-x-twitter aria-hiddentrue>/i> span classvisually-hidden>Twitter opens in new window/span> /a> /li> li classnav-item> a hrefhttps://www.linkedin.com/company/q32-bio-inc aria-labelLinkedin opens in new window titleLinkedin opens in new window classnav-link hover-scale-1 d-block target_blank> i classfab fa-lg fa-linkedin aria-hiddentrue>/i> span classvisually-hidden>Linkedin opens in new window/span> /a> /li> /ul> /nav> /div> /div> /div> /div> /div>/footer>!-- Video Modal -->div classndm-modal fade idvideoModal tabindex-1 roledialog aria-labelVideo Modal aria-hiddentrue> div classndm-modal-dialog ndm-modal-dialog-centered ndm-modal-xl> div classndm-modal-content> div classndm-modal-header> button typebutton classbtn-close data-bs-dismissndm-modal aria-labelClose>/button> /div> div classndm-modal-body> div classvideoWrapper>iframe titlevideo-player src>/iframe>/div> /div> /div> /div>/div>!-- Bio Modal -->div classndm-modal bios-modal fade idmodalBio tabindex-1 roledialog aria-labelledbymodalBioTitle aria-hiddentrue> div classndm-modal-dialog ndm-modal-dialog-centered ndm-modal-lg roledocument> div classndm-modal-content border-0 p-4 idm-rounded> div classndm-modal-header> div classrow w-100 d-flex flex-row-reverse> div classcol text-end> button typebutton classbtn-close data-bs-dismissndm-modal aria-labelClose>/button> /div> div classcol-sm-12 col-md-6 col-lg-5 align-self-end> div classh4 mb-0 modal-bio-name text-primary idmodalBioTitle>!-- dynamic from JS -->/div> div classh5 body-font mb-0 modal-bio-title>!-- dynamic from JS -->/div> /div> div classcol-sm-12 col-md-4 col-lg-3 > div classportrait> img src classobject-top modal-bio-pic w-100 alt>!-- dynamic from JS --> /div> /div> /div> /div> div classndm-modal-body modal-bio-body>!-- dynamic from JS -->/div> /div> /div>/div>!-- Bio Offcanvas -->div classoffcanvas offcanvas-end bios-offcanvas tabindex-1 idbioCanvas aria-labelledbybiosOffcanvasLabel> div classoffcanvas-header flex-column-reverse> div classalign-self-start w-100> div classrow w-100> div classcol-md-3> div classportrait mt-5> img src classobject-top offcanvas-bio-pic w-100 alt>!-- dynamic from JS --> /div> /div> div classcol-md-9> div classh4 offcanvas-title mt-5 offcanvas-bio-name idbiosOffcanvasLabel>!-- dynamic from JS -->/div> div class offcanvas-bio-title h6 body-font>!-- dynamic from JS -->/div> /div> /div> /div> button typebutton classbtn-close text-reset align-self-end data-bs-dismissoffcanvas aria-labelClose>/button> /div> div classoffcanvas-body> div classoffcanvas-bio-body>!-- dynamic from JS -->/div> /div>/div>!-- Search Modal -->div classndm-modal fade idsearchModal tabindex-1 aria-labelledbysearchModalLabel aria-hiddentrue> div classndm-modal-dialog ndm-modal-dialog-centered ndm-modal-lg> div classndm-modal-content> div classndm-modal-header> div classh5 modal-title idsearchModalLabel>Search Investors/div> button typebutton classbtn-close data-bs-dismissndm-modal aria-labelClose>/button> /div> div classndm-modal-body> form classrow g-3> div classcol-auto flex-grow-1> label forsiteSearch classvisually-hidden>Search this site/label> input typesearch classform-control idsiteSearch placeholderSearch> /div> div classcol-auto> button typesubmit classbtn btn-primary mb-3>Submit/button> /div> /form> /div> /div> /div>/div> /div> script typetext/javascript>var s_CCSWebHostingAccount trcghomologymedicinesinc;/script> script typeapplication/json data-drupal-selectordrupal-settings-json>{path:{baseUrl:\/,pathPrefix:,currentPath:node\/5806,currentPathIsAdmin:false,isFront:true,currentLanguage:en,themeUrl:sites\/g\/files\/knoqqb90916\/themes\/site\/client_site},pluralDelimiter:\u0003,suppressDeprecationErrors:true,ajaxPageState:{libraries:eJyVUgFuwyAM_FAV3rIXWAaslgXsynbW5vcjpFKVqZs6IYF9nA_kc6qF2MGKU5Av0pv2yE5cFJCxrl6ShUM2YZZIUHHhdHmDeFXJgxbRaDBKErYj5CI1og4wzZSLi0JG7ytWsvAMB6WhzuSDALFKmsN41RwUvfC5C3edC6q_RTcY2r9wGyGDUpLWiDtehP_UfolOWzly_leNed8_FvHH15bqpfXmYDim4_aK572XWzDhJ94Bc4ZU0Qywkrq94HUrfAzAyql3jZl2E24Ut5kAlm4l7c7-wKbHeVLM5d4HYpXFLRyyk_UuUwub0d8l-PZR,theme:client_site,theme_token:null},ajaxTrustedUrl:,nir_admin_use_chosen:false,nir_admin_use_select2:false,accessible_accordions:true,chairtextvars:{chairpersontext:Committee Chair,chairtext:Chair},lfg_accordions:{no_functionality:1,speed:fast,show_text:Show All,hide_text:Hide All,show_all:0},lfg_chosen:{enabled:1,blank_text:Choose from list,disable_search:1,disable_search_threshold:10},user:{uid:0,permissionsHash:bcc54a4e918bfae7428a047c8b96ef9eb631f4a1ef5400a422dfda45a069bd65}}/script>script srchttps://code.jquery.com/jquery-3.6.0.min.js>/script>script srchttps://code.jquery.com/jquery-migrate-3.4.0.min.js>/script>script src/sites/g/files/knoqqb90916/files/js/js_4c4e5ojqV_TiNbFoeyTRMANP_1c1ag6xp-1JD9Oj23U.js?scopefooter&delta2&languageen&themeclient_site&includeeJyVUFsOAjEIvJBpz-IJCKVE69KyaVkft7d2NWaNHxoSmBmGBCBJXAxaMvZ65nqpHbVdSRWwoNwsUfMb5jBqYBBcCh1_MM5V47DRxDGZVohoPYJw8284LBnrxDYMEERp8l9VR5ozlvjXTLOe94sar2OLWMp9I_RbOrozHti_gMMTXgFjBBJsDVC42rrwhcPjdVC0X8zrAz4096x3KCyQDg>/script>script srchttps://cdnjs.cloudflare.com/ajax/libs/waypoints/4.0.1/jquery.waypoints.min.js>/script>script src/sites/g/files/knoqqb90916/files/js/js_VU1nD70aQBCRKDsVri1ruZKmDfFVoesonUHsxOz09Sw.js?scopefooter&delta4&languageen&themeclient_site&includeeJyVUFsOAjEIvJBpz-IJCKVE69KyaVkft7d2NWaNHxoSmBmGBCBJXAxaMvZ65nqpHbVdSRWwoNwsUfMb5jBqYBBcCh1_MM5V47DRxDGZVohoPYJw8284LBnrxDYMEERp8l9VR5ozlvjXTLOe94sar2OLWMp9I_RbOrozHti_gMMTXgFjBBJsDVC42rrwhcPjdVC0X8zrAz4096x3KCyQDg>/script>script srchttps://cdn.jsdelivr.net/npm/@popperjs/core@2.11.6/dist/umd/popper.min.js>/script>script src/sites/g/files/knoqqb90916/files/js/js_j5QrRtJ4XoW8YhWnxmyBL4fzXM5PebPraIWZ5qSaPgI.js?scopefooter&delta6&languageen&themeclient_site&includeeJyVUFsOAjEIvJBpz-IJCKVE69KyaVkft7d2NWaNHxoSmBmGBCBJXAxaMvZ65nqpHbVdSRWwoNwsUfMb5jBqYBBcCh1_MM5V47DRxDGZVohoPYJw8284LBnrxDYMEERp8l9VR5ozlvjXTLOe94sar2OLWMp9I_RbOrozHti_gMMTXgFjBBJsDVC42rrwhcPjdVC0X8zrAz4096x3KCyQDg>/script>script srchttps://unpkg.com/aos@2.3.1/dist/aos.js>/script>script srchttps://unpkg.com/swiper@8/swiper-bundle.min.js>/script>script src/sites/g/files/knoqqb90916/files/js/js_pn9ckQfb25RZdmqxNkxRuMxyozQ15ptBhj05WsCG2Oo.js?scopefooter&delta9&languageen&themeclient_site&includeeJyVUFsOAjEIvJBpz-IJCKVE69KyaVkft7d2NWaNHxoSmBmGBCBJXAxaMvZ65nqpHbVdSRWwoNwsUfMb5jBqYBBcCh1_MM5V47DRxDGZVohoPYJw8284LBnrxDYMEERp8l9VR5ozlvjXTLOe94sar2OLWMp9I_RbOrozHti_gMMTXgFjBBJsDVC42rrwhcPjdVC0X8zrAz4096x3KCyQDg>/script>script srchttps://assets.adobedtm.com/898335afd880/c52ee8aa1e90/launch-5ef258dce664.min.js crossoriginanonymous async integritysha384-9QSqHMB+yiy/V4i+d2Au+ydEWbBz4E9DqsE+oYKOnL+kj4XAZGYZxabd0P3OGHkf>/script>script src/core/assets/vendor/ckeditor5/ckeditor5-dll/ckeditor5-dll.js?v44.0.0>/script>script src/profiles/nasdaqir/modules/custom/nir_ckeditor_datatables/js/build/datatables.js?v1.10.9>/script>script src/sites/g/files/knoqqb90916/files/js/js_zLB5qILYeTu4udV6e9Q1revuyXJkS9XdHJsEmE0KyBA.js?scopefooter&delta13&languageen&themeclient_site&includeeJyVUFsOAjEIvJBpz-IJCKVE69KyaVkft7d2NWaNHxoSmBmGBCBJXAxaMvZ65nqpHbVdSRWwoNwsUfMb5jBqYBBcCh1_MM5V47DRxDGZVohoPYJw8284LBnrxDYMEERp8l9VR5ozlvjXTLOe94sar2OLWMp9I_RbOrozHti_gMMTXgFjBBJsDVC42rrwhcPjdVC0X8zrAz4096x3KCyQDg>/script> /body>/html>
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]